Insmed Incorporated
INSM
$64.97
-$3.12-4.58%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | 104.44M | 93.43M | 90.34M | 75.50M | 83.69M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 104.44M | 93.43M | 90.34M | 75.50M | 83.69M |
| Cost of Revenue | 26.15M | 21.17M | 20.96M | 17.46M | 18.44M |
| Gross Profit | 78.29M | 72.26M | 69.38M | 58.04M | 65.25M |
| SG&A Expenses | 142.52M | 118.93M | 106.57M | 93.10M | 89.53M |
| Depreciation & Amortization | 1.26M | 1.26M | 1.26M | 1.26M | 1.26M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 349.66M | 292.17M | 275.54M | 232.91M | 246.27M |
| Operating Income | -245.21M | -198.75M | -185.20M | -157.41M | -162.57M |
| Income Before Tax | -234.28M | -219.51M | -299.77M | -156.50M | -185.06M |
| Income Tax Expenses | 1.27M | 1.01M | 838.00K | 589.00K | 998.00K |
| Earnings from Continuing Operations | -235.55M | -220.52M | -300.61M | -157.09M | -186.06M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -235.55M | -220.52M | -300.61M | -157.09M | -186.06M |
| EBIT | -245.21M | -198.75M | -185.20M | -157.41M | -162.57M |
| EBITDA | -243.01M | -196.56M | -183.04M | -155.09M | -160.37M |
| EPS Basic | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 |
| Normalized Basic EPS | -0.87 | -0.74 | -0.79 | -0.71 | -0.73 |
| EPS Diluted | -1.32 | -1.27 | -1.94 | -1.06 | -1.28 |
| Normalized Diluted EPS | -0.87 | -0.74 | -0.79 | -0.71 | -0.73 |
| Average Basic Shares Outstanding | 179.02M | 173.72M | 154.70M | 148.46M | 144.81M |
| Average Diluted Shares Outstanding | 179.02M | 173.72M | 154.70M | 148.46M | 144.81M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
